Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 190
Endocrine and Metabolic Disorders Drugs 162
Gastrointestinal Drugs 147
Central Nervous System Drugs 127
Immune Disorders Drugs 127
Pharmaceuticals 87
Biopharmaceuticals 85
Hematological Drugs 78
Vaccines 78
Clinical Trials 68
Drug Discovery 64
Cardiovascular Drugs 60
Diabetes Drugs 56
Infectious Diseases Drugs 56
Leukemia Drugs 53
Mental Disorders Drugs 46
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 41
Liver and Kidney Disorders Drugs 32
Infusions and Injectables 31
Over the Counter (OTC) Drugs 30
Lung Cancer Drugs 23
Pharmaceutical Manufacturing 20
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Respiratory Drugs 18
Antibiotics 16
Analgesics 15
Drugs by Therapeutic Area 13
Pharmaceutical Intermediates 12
Schizophrenia Drugs 12
Immunosuppressive Drugs 12
Prostate Cancer Drugs 11
Skin Cancer Drugs 11
Optical Disorders Drugs 10
Anti-Obesity Drugs 9
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Thyroid Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Transdermal and Transmucosal Drug Delivery 5
Uterine Cancer Drugs 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Brain Cancer Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Cough and Cold Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

1,638 Results (Page 40 of 82)
- Relevance
  Sort by

Diabetic Therapeutic Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
February 2024
93 Pages
Global

From

€3500EUR$4,121USD£3,094GBP

Gaucher Disease Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
February 2024
86 Pages
Global

From

€3500EUR$4,121USD£3,094GBP

Fabry Disease Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
February 2024
90 Pages
Global

From

€3500EUR$4,121USD£3,094GBP

Biosimilars Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4085EUR$4,490USD£3,489GBP

Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type, Drug Type, Route of Administration, and Region 2026-2034

 Report
May 2026
149 Pages
Global

From

€2729EUR$2,999USD£2,330GBP

€3638EUR$3,999USD£3,107GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Biosimilar Therapeutic Peptides Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4085EUR$4,490USD£3,489GBP

Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

 Report
October 2023
74 Pages
Global

From

€3180EUR$3,495USD£2,716GBP

Lennox-Gastaut Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
September 2023
169 Pages
Global

From

€2275EUR$2,500USD£1,943GBP

Acute Lymphoblastic Leukemia Treatment Market by Treatment Type, Disease Stage, Route of Administration, Patient Age Group, Distribution Channel - Global Forecast 2026-2032

 Report
June 2026
186 Pages
Global

From

€3225EUR$3,545USD£2,755GBP

€3584EUR$3,939USD£3,061GBP

Multiple Myeloma Drug Market by Drug Class, Line of Therapy, Treatment Regimen, Route of Administration, Patient Age, Line of Treatment, Patient Type, End-User - Global Forecast 2026-2032

 Report
June 2026
195 Pages
Global

From

€3225EUR$3,545USD£2,755GBP

€3584EUR$3,939USD£3,061GBP

Myelodysplastic Syndrome Market by Product Type, Therapy Line, Treatment Type, Route of Administration, End User, Distribution Channel - Global Forecast 2026-2032

 Report
June 2026
184 Pages
Global

From

€3225EUR$3,545USD£2,755GBP

€3584EUR$3,939USD£3,061GBP

D Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1365EUR$1,500USD£1,166GBP

Multiple Myeloma Therapeutics Market by Drug Class, Mode of Administration, Line of Therapy, Distribution Channel, End User - Global Forecast 2026-2032

 Report
June 2026
182 Pages
Global

From

€3225EUR$3,545USD£2,755GBP

€3584EUR$3,939USD£3,061GBP

Non-Small Cell Lung Cancer (NSCLC) Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4085EUR$4,490USD£3,489GBP

Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
October 2022
182 Pages
Global

From

€2275EUR$2,500USD£1,943GBP

Acute Myeloid Leukemia (AML) - Pipeline Insight, 2026

 Clinical Trials
April 2026
450 Pages
Global

From

€4549EUR$5,000USD£3,885GBP

Fungal Keratitis Treatment - Global Strategic Business Report

 Report
July 2026
484 Pages
Global

From

€5322EUR$5,850USD£4,546GBP

Lung Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4085EUR$4,490USD£3,489GBP

Metastatic Melanoma Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4085EUR$4,490USD£3,489GBP

Melanoma Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4085EUR$4,490USD£3,489GBP

1,638 Results (Page 40 of 82)
- 1
- 38
- 39
- 40
- 41
- 42

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.